Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CTX131 |
Synonyms | |
Therapy Description |
CTX131 are allogeneic T-lymphocytes engineered to harbor modifications of Regnase-1 and TGFBR2 and express a chimeric antigen receptor (CAR) targeting CD70, which potentially lead to enhanced antitumor immune response and inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): ND02). |